Trigilio Jeffrey 4
4 · Cullinan Oncology, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Trigilio Jeffrey
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-30$8.97/sh+201$1,803→ 41,402 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on December 30, 2022.